Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T12:18:55.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision label in the site footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:33:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The METEOR study record page now displays a 403 Forbidden error, replacing the usual study details with an error screen and removing access to the study content.
    Difference
    15%
    Check dated 2026-09-21T20:39:24.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.5 to v3.6.6, reflecting a version update to the page's underlying documentation or software. This indicates the content has been refreshed at the system level rather than adding new study information.
    Difference
    0.0%
    Check dated 2026-08-31T17:16:28.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now displays a new revision label, v3.6.5, replacing the previous v3.6.4 to reflect a small backend or build update.
    Difference
    0.0%
    Check dated 2026-08-10T10:36:49.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added, replacing the previous Revision: v3.6.3. This reflects a minor update to the page version with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-27T05:42:23.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.